Abstract

Review Article

Laparoscopic staging of borderline ovarian tumours – Technique and results

Klimatsouda M, Donoudis C, Kontopoulos G and Daponte A*

Published: 17 March, 2021 | Volume 4 - Issue 1 | Pages: 020-024

Borderline Ovarian Tumors (BOT) tend to present more frequently nowadays, especially in younger women. Furthermore fertility preservation and laparoscopic management is often desired and therefore appropriate counselling is challenging and the treatment selection must be made on evidence based medicine.

Adnexal mass could be a random finding when a typical gynecologic examination is performed. The diagnostic algorithm for possible BOT is the same as for any ovarian tumor, but the treatment options and techniques may vary based on patient’s willing to preserve her fertility or not. Laparoscopic or laparotomy approach has similar results although intraoperative findings and frozen section may redirect the primary treatment planning.

When an initial conservative approach is chosen, a secondary approach including total hysterectomy and bilateral salpingo-oophorectomy with staging should be considered. Hence a full counselling is recommended before any primary approach.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001081 Cite this Article Read Full Article PDF

Keywords:

Borderline; Ovarian tumor; Laparoscopy; Staging; Fertility preservation

References

  1. Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. 2013: CD008215. PubMed: https://pubmed.ncbi.nlm.nih.gov/23943232/
  2. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol. 2002; 155: 217-224. PubMed: https://pubmed.ncbi.nlm.nih.gov/11821246/
  3. Kimura E, Murae M, Koga R, Odawara Y, Nakabayashi Y, et al. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer]. Nihon Sanka Fujinka Gakkai Zasshi. 1984; 36: 2121-2128. PubMed: https://pubmed.ncbi.nlm.nih.gov/6595320/
  4. Shimada K, Matsumoto K, Mimura T, Ishikawa T, Munechika J, et al. Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study. Int J Clin Oncol. 2018; 514-521. PubMed: https://pubmed.ncbi.nlm.nih.gov/29236181/
  5. Tropé CG, Kaern J, Davidson B. Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol. 2012; 26: 325-336. PubMed: https://pubmed.ncbi.nlm.nih.gov/22321906/
  6. Im SS, Gordon AN, Buttin BM, Leath CA, Gostout BS, et al. Validation of Referral Guidelines for Women with Pelvic Masses. Obstet Gynecol. 2005; 105: 35-41. PubMed: https://pubmed.ncbi.nlm.nih.gov/15625139/
  7. Park JY, Kim DY, Kim JH, Kim YM, Kim KR, et al. Micropapillary pattern in serous borderline ovarian tumors: does it matter? Gynecol Oncol. 2011; 123: 511-516. PubMed: https://pubmed.ncbi.nlm.nih.gov/21917305/
  8. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Human Pathol. 2000; 31: 539-557. PubMed: https://pubmed.ncbi.nlm.nih.gov/10836293/
  9. Lesieur B, Kane A, Duvillard P, Gouy S, Pautier P, et al. Prognostic value of lymph node involvement in ovarian serous borderline tumors. Am J Obstet Gynecol. 2011: 204: e1–7. PubMed: https://pubmed.ncbi.nlm.nih.gov/21349494/
  10. Desfeux P, Camatte S, Chatellier G, Blanc B, Querleu D, et al. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol.2005; 98: 390-395. PubMed: https://pubmed.ncbi.nlm.nih.gov/16043215/
  11. Moroney MR,Berning AA,Sheeder J,Corr BR. An Evaluation of Frozen Section and Lymph Node Dissection results for Mucinous Ovarian Tumors. Int J Gynecol Cancer.2018; 28:92-98. PubMed: https://pubmed.ncbi.nlm.nih.gov/29194190/
  12. Camatte S, Morice P,Atallah D,Thoury A,Pautier P,et al. Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients. Ann Oncol. 2004; 15: 605–609. PubMed: https://pubmed.ncbi.nlm.nih.gov/15033667/
  13. Nezhat FR, Pejovic T, Finger TN, Khalil SS. Role of minimally invasive surgery in ovarian cancer. J Minim Invasive Gynecol.2013; 20: 754-765. PubMed: https://pubmed.ncbi.nlm.nih.gov/24183269/
  14. Fang C, Zhao L, Chen X, Yu A, Xia L, et al. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤ 40years old) with borderline ovarian tumors. BMC Cancer.2018; 18: 1147. PubMed: https://pubmed.ncbi.nlm.nih.gov/30463533/
  15. Sánchez J,Rosado R, Ramírez D, Medina P, Mezquita S, et al. Torsion of the greater omentum: treatment bylaparoscopy. Surg Laparosc Endosc Percutan Tech.2002; 12: 443-445.
  16. GulYA, Jabbar MF, Moissinac K. Primary torsion of the greater omentum. Acta Chir Belg. 2001; 101: 312-314. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11868511
  17. Azuar AS, Bourdel N, Ferrarrese G, Dauplat J, Mage G, et al. Laparoscopic restaging of borderline ovarian tumours (BLOT): a retrospective study of 142 cases. Eur J Obstet Gynecol Reprod Biol. 2013; 168: 87–91. PubMed: https://pubmed.ncbi.nlm.nih.gov/23395007/
  18. David M. Gershenson. Management of Borderline Ovarian Tumours. Best Pract Res Clin Obstet Gynaecol. PubMed: https://pubmed.ncbi.nlm.nih.gov/27780698/
  19. Huang Y, Zhang W, Wang Y. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis, Taiwanese J Obstet Gynecol. 2016; 55: 319-325. PubMed: https://pubmed.ncbi.nlm.nih.gov/27343308/
  20. Jiao X, Hu J, Zhu L. Prognostic Factors for Recurrence After Fertility-Preserving Surgery in Patients With Borderline Ovarian Tumors .A Systematic Review and Meta-analysis of Observational Studies Int J Gynecol Cancer. 2017; 27: 1833-1841. PubMed: https://pubmed.ncbi.nlm.nih.gov/28816706/
  21. Qian X, Hua X, Wu J, Shen Y, Cheng X, et al. Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor. Int J Gynecol Cancer. 2018: 28: 279-284. PubMed: https://pubmed.ncbi.nlm.nih.gov/29194193/
  22. Vasconcelos I, de Sousa Mendes M. Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence risk. Eur J Cancer. 2015: 51: 620-631. PubMed: https://pubmed.ncbi.nlm.nih.gov/25661104/
  23. Tinelli R, Malzoni M, Cosentino F, Perone C, Tinelli A, et al. Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors. Fertil Steril. 2009; 92: 736-741. PubMed: https://pubmed.ncbi.nlm.nih.gov/18793773/ B
  24. Song T, Kimb MK, Jung YW, Yun BS, Seong SJ, et al. Minimally invasive compared with open surgery in patients with borderline ovarian tumors. Gynecol Oncol. 2017; 145: 508–512. PubMed: https://pubmed.ncbi.nlm.nih.gov/28381342/
  25. Chen CH, Chiu LH, Chen HH, Chan C, Liu WM. Comparison of robotic approach, laparoscopic approach and laparotomy in treating epithelial ovarian cancer. Int J Med Robot. 2016; 12: 268–275. PubMed: https://pubmed.ncbi.nlm.nih.gov/25808671/
  26. Zhao J, Liu C, Liu J, Qu P. Short-term Outcomes and Pregnancy Rate After Laparoscopic Fertility-Sparing Surgery for Borderline Ovarian Tumors .A Single-Institute Experience. Int J Gynecol Cancer. 2018; 28: 274-278. PubMed: https://pubmed.ncbi.nlm.nih.gov/29324543/
  27. Jiao X, Hu J, Zhu L. Prognostic Factors for Recurrence After Fertility-Preserving Surgery in Patients With Borderline Ovarian Tumors .A Systematic Review and Meta-analysis of Observational Studies. Int J Gynecol Cancer. 2017; 27: 1833-1841. PubMed: https://pubmed.ncbi.nlm.nih.gov/28816706/
  28. Lee JH, Kim J. Surgical Techniques of Laparoscopic Omentectomy. Springer International Publishing Switzerland 2018 737 Alkatout, L. Mettler (eds.), Hysterectomy. 2018.
  29. Fauvet R, Boccara J, Dufournet C, Poncelet C, Daraı E. Laparoscopic management of borderline ovarian tumors:results of a French multi center study. Ann Oncol. 2005; 16: 403–410. PubMed: https://pubmed.ncbi.nlm.nih.gov/15653700/
  30. Shin YJ, Lee HJ, Kim KR, Nam JH, Park JY. Port-site recurrence 6 years after laparoscopic surgery for early stage ovarian borderline malignancy. J Obstetr Gynaecol. 2017; 38:2, 291-292. PubMed: https://pubmed.ncbi.nlm.nih.gov/28830247/
  31. Radosa JC, Radosa MP, Schweitzer PA, Juhasz‑Boess I, Rimbach S, et al. Report of the survey on current opinions and practice of German Society for Gynecologic Endoscopy (AGE) members regarding the laparoscopic treatment of ovarian malignancies. Arch Gynecol Obstet. 2018; 297: 1255– PubMed: https://pubmed.ncbi.nlm.nih.gov/29520665/

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More